조희진 (경북대학교)님 | 한빛사연구자 > 한빛사

경북대학교

최종업데이트 2024.01.24.

Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
- Nat. Commun., 23 January 2024 | https://doi.org/10.1038/s41467-024-44875-2
- 2024-01
- 의약학
- 한빛사논문
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intratumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
- Genome Med., Published: 06 January 2022, 14, Article number: 1 | https://doi.org/10.1186/s13073-021-00995-8
- 2022-01
- 의약학
- 한빛사논문
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
- Genome Biol., Published: 26 August 2020, 21, Article number: 216 (2020) | https://doi.org/10.1186/s13059-020-02140-x
- 2020-08
- 의약학
- 한빛사논문
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
- Nat. Commun., Published: 03 July 2020, 11, Article number: 3288 (2020) | https://doi.org/10.1038/s41467-020-17139-y
- 2020-07
- 의약학
- 한빛사논문
Spatiotemporal Evolution of the Primary Glioblastoma Genome
- Cancer Cell, Volume 28, Issue 3, p318–328, 14 September 2015 | DOI: http://dx.doi.org/10.1016/j.ccell.2015.07.013
- 2015-09
- 의약학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문